CoChat

Metformin vs. insulin in gestational diabetes. A randomized study characterizing metformin patients needing additional insulin

Tertti, K., Ekblad, U., Koskinen, P., Vahlberg, T., Rönnemaa, T. · 2013 · Diabetes, Obesity and Metabolism
Cited by 174

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

Aims: We compared metformin with insulin as treatment of gestational diabetes mellitus ( GDM ). Furthermore, we aimed to characterize metformin‐treated patients needing additional insulin to achieve prespecified glucose targets. Methods: We conducted a single centre randomized controlled study with non‐inferiority design comparing metformin and insulin in the treatment of 217 GDM patients having birth weight as primary outcome variable. Results: There were no significant differences in mean birth weight expressed in grams [+15 (90% confidence interval ( CI ): −121 to 89)] or SD units [+0.04 (90% CI : −0.27 to 0.18)] between the metformin and insulin groups. There were no significant differences in neonatal or maternal data between the groups. Only 23 (20.9%) of the 110 patients in the metformin group needed additional insulin. Compared with the patients on metformin only, those needing additional insulin were older (p = 0.04), their oral glucose tolerance test had been performed earlier and diabetes therapy started earlier in gestation (p = 0.01 and p = 0.004, respectively). The risk for additional insulin was 4.6‐fold in women with baseline serum fructosamine concentration above median compared with those below median. Conclusions: Metformin is an effective alternative to insulin in the treatment of GDM patients. Serum fructosamine may help in predicting the adequacy of metformin treatment alone.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/dom.12017

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

Metadata

Authors
Tertti, K., Ekblad, U., Koskinen, P., Vahlberg, T., & Rönnemaa, T.
Venue
Diabetes, Obesity and Metabolism
Publisher
Wiley
Published
2012-10-24
Volume
15
Issue
3
Pages
246-251
ISSN
  • 1462-8902 (ISSN-L)
  • 1463-1326
OpenAlex
W2152958267
Cited by
174
References
8
FWCI
11.19
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.